{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:04:23Z","timestamp":1793703863307,"version":"4.5.1"},"reference-count":56,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-004713"],"award-info":[{"award-number":["INV-004713"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,11,25]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The optimal dosing of primaquine to prevent relapsing <jats:italic>Plasmodium vivax<\/jats:italic> malaria in South Asia remains unclear. We investigated the efficacy and safety of different primaquine regimens to prevent <jats:italic>P. vivax<\/jats:italic> relapse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic review identified <jats:italic>P. vivax<\/jats:italic> efficacy studies from South Asia published between 1 January 2000 and 23 August 2021. In a one-stage meta-analysis of available individual patient data, the cumulative risks of <jats:italic>P. vivax<\/jats:italic> recurrence at day 42 and 180 were assessed by primaquine total mg\/kg dose and duration. The risk of recurrence by day 180 was also determined in a two-stage meta-analysis. Patients with a &gt;25%\u2009drop in haemoglobin to &lt;70\u2009g\/L, or an absolute drop of &gt;50\u2009g\/L between days 1 and 14 were categorised by daily mg\/kg primaquine dose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 791 patients from 7 studies in the one-stage meta-analysis, the day 180 cumulative risk of recurrence was 61.1% (95% CI 42.2% to 80.4%; 201 patients; 25 recurrences) after treatment without primaquine, 28.8% (95% CI 8.2% to 74.1%; 398 patients; 4 recurrences) following low total (2 to &lt;5\u2009mg\/kg) and 0% (96 patients; 0 recurrences) following high total dose primaquine (\u22655\u2009mg\/kg). In the subsequent two-stage meta-analysis of nine studies (3529 patients), the pooled proportions of <jats:italic>P. vivax<\/jats:italic> recurrences by day 180 were 12.1% (95% CI 7.7% to 17.2%), 2.3% (95% CI 0.3% to 5.4%) and 0.7% (95% CI 0% to 6.1%), respectively. No patients had a &gt;25%\u2009drop in haemoglobin to &lt;70\u2009g\/L.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Primaquine treatment led to a marked decrease in <jats:italic>P. vivax<\/jats:italic> recurrences following low (~3.5\u2009mg\/kg) and high (~7\u2009mg\/kg) total doses, with no reported severe haemolytic events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42022313730.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2023-012675","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T13:10:11Z","timestamp":1703077811000},"page":"e012675","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Safety and efficacy of primaquine in patients with <i>Plasmodium vivax<\/i> malaria from South Asia: a systematic review and individual patient data meta-analysis"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9870-6017","authenticated-orcid":false,"given":"Reena","family":"Verma","sequence":"first","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Commons","sequence":"additional","affiliation":[{"name":"Global Health Division, Menzies School of Health Research, Charles Darwin University, Tiwi, Northern Territory, Australia"},{"name":"WorldWide Antimalarial Resistance Network, Asia Pacific Regional Hub - Australia, Melbourne, Victoria, Australia"},{"name":"General and Subspecialty Medicine, Grampians Health Ballarat, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorv","family":"Gupta","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0932-0935","authenticated-orcid":false,"given":"Manju","family":"Rahi","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"},{"name":"Indian Council of Medical Research, New Delhi, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nitika","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K","family":"Bharti","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[{"name":"Global Health Division, Menzies School of Health Research, Charles Darwin University, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Rajasekhar","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauman","family":"Singh-Phulgenda","sequence":"additional","affiliation":[{"name":"WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK"},{"name":"Infectious Diseases Data Observatory (IDDO), Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-3910","authenticated-orcid":false,"given":"Bipin","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shafiul","family":"Alam","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-412X","authenticated-orcid":false,"given":"Prakash","family":"Ghimire","sequence":"additional","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kirtipur, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasif A","family":"Khan","sequence":"additional","affiliation":[{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishikesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Malaria Research, New Delhi, India"},{"name":"ICMR-Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK"},{"name":"HealthNet TPO, Kabul, Afghanistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Ley","sequence":"additional","affiliation":[{"name":"Global Health Division, Menzies School of Health Research, Charles Darwin University, Tiwi, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Llanos-Cuentas","sequence":"additional","affiliation":[{"name":"Unit of Leishmaniasis and Malaria, Instituto de Medicina Tropical \u201cAlexander von Humboldt\u201d, Universidad Peruana Cayetano Heredia, Lima, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasithon","family":"Pukrittayakamee","sequence":"additional","affiliation":[{"name":"Mahidol Oxford Tropical Medicine Research Unit (MORU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6281-8236","authenticated-orcid":false,"given":"Komal Raj","family":"Rijal","sequence":"additional","affiliation":[{"name":"Central Department of Microbiology, Tribhuvan University, Kirtipur, Nepal"},{"name":"Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rowland","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-1129","authenticated-orcid":false,"given":"Kavitha","family":"Saravu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"},{"name":"Manipal Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Simpson","sequence":"additional","affiliation":[{"name":"WorldWide Antimalarial Resistance Network, Asia Pacific Regional Hub - Australia, Melbourne, Victoria, Australia"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":false,"given":"Philippe J","family":"Guerin","sequence":"additional","affiliation":[{"name":"WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK"},{"name":"Infectious Diseases Data Observatory (IDDO), Oxford, UK"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N","family":"Price","sequence":"additional","affiliation":[{"name":"Global Health Division, Menzies School of Health Research, Charles Darwin University, Tiwi, Northern Territory, Australia"},{"name":"WorldWide Antimalarial Resistance Network, Asia Pacific Regional Hub - Australia, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3305-0034","authenticated-orcid":false,"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"International Centre For Genetic Engineering and Biotechnology, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"2025073012453431000_8.12.e012675.1","unstructured":"World Health Organization (WHO) . World malaria report. Geneva World Health Organization; 2022. Available: https:\/\/www.mmv.org\/newsroom\/publications\/who-world-malaria-report-2022 [Accessed 23 Jan 2023]."},{"key":"2025073012453431000_8.12.e012675.2","unstructured":"National Vector Borne Disease Control Programme . Malaria: national center for vector borne diseases control (NCVBDC). Ministry of health and family welfare, government of India. Available: https:\/\/nvbdcp.gov.in [Accessed 16 Dec 2022]."},{"key":"2025073012453431000_8.12.e012675.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001575","article-title":"Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study","volume":"10","author":"Douglas","year":"2013","journal-title":"PLoS Med"},{"key":"2025073012453431000_8.12.e012675.4","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline, therapy for latent malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2025073012453431000_8.12.e012675.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-017-1784-1","article-title":"Challenges for achieving safe and effective radical cure of Plasmodium Vivax: a round table discussion of the APMEN Vivax working group","volume":"16","author":"Thriemer","year":"2017","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-021-03803-1","article-title":"Usability of a point-of-care diagnostic to identify Glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation","volume":"20","author":"Gerth-Guyette","year":"2021","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.7","unstructured":"World Health Organization . WHO guidelines for malaria 2022. Geneva, Switzerland World Health Organization; 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria [Accessed 23 Jan 2023]."},{"key":"2025073012453431000_8.12.e012675.8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/347018"},{"key":"2025073012453431000_8.12.e012675.9","article-title":"Sustained release formulation of primaquine for prevention of relapse of Plasmodium Vivax malaria: a randomized, double-blind, comparative, multicentric study","volume":"2015","author":"Pareek","year":"2015","journal-title":"Malar Res Treat"},{"key":"2025073012453431000_8.12.e012675.10","doi-asserted-by":"crossref","unstructured":"Commons RJ , Rajasekhar M , Edler P , et al . Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium Vivax: a systematic review and individual patient data meta-analysis [published online ahead of print, 2023 Sep 22]. Lancet Infect Dis 2023. doi:10.1016\/S1473-3099(23)00430-9","DOI":"10.1016\/S1473-3099(23)00430-9"},{"key":"2025073012453431000_8.12.e012675.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(03)00041-5"},{"key":"2025073012453431000_8.12.e012675.12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1473-3099(21)00358-3","article-title":"Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and Vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial","volume":"22","author":"Poespoprodjo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025073012453431000_8.12.e012675.13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium Vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019","journal-title":"Lancet"},{"key":"2025073012453431000_8.12.e012675.14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy735"},{"key":"2025073012453431000_8.12.e012675.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003494","article-title":"Towards the elimination of Plasmodium Vivax malaria: implementing the radical cure","volume":"18","author":"Thriemer","year":"2021","journal-title":"PLoS Med"},{"key":"2025073012453431000_8.12.e012675.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104226"},{"key":"2025073012453431000_8.12.e012675.17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpddr.2017.03.003","article-title":"The Vivax surveyor: online mapping database for Plasmodium Vivax clinical trials","volume":"7","author":"Commons","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2025073012453431000_8.12.e012675.18","unstructured":"Infectious Diseases Data Observatory . IDDO SDTM implementation manual. 2023. Available: https:\/\/wiki.iddo.org\/en\/DataEngineering\/IDDO-SDTM-Implementation-Manual [Accessed 29 Aug 2023]."},{"key":"2025073012453431000_8.12.e012675.19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","article-title":"Mapping the global endemicity and clinical burden of Plasmodium Vivax, 2000-17: a spatial and temporal modelling study","volume":"394","author":"Battle","year":"2019","journal-title":"Lancet"},{"key":"2025073012453431000_8.12.e012675.20","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2509-9","article-title":"Anaemia and malaria","volume":"17","author":"White","year":"2018","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.21","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-7-149","article-title":"The relationship between the haemoglobin concentration and the haematocrit in Plasmodium Falciparum malaria","volume":"7","author":"Lee","year":"2008","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.22","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7141"},{"key":"2025073012453431000_8.12.e012675.23","unstructured":"Higgins JPT , Savovi\u0107 J , Page MJ , et al . Chapter 8: assessing risk of bias in a randomized trial. In: Higgins JPT , Thomas J , Chandler J , et al , eds. Cochrane Handbook for Systematic Reviews of Interventions version 63. Cochrane, 2022. Available: www.training.cochrane.org\/handbook"},{"key":"2025073012453431000_8.12.e012675.24","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000054"},{"key":"2025073012453431000_8.12.e012675.25","unstructured":"WorldWide Antimalarial Resistance Network . WWARN Primaquine Indian region study group statistical analysis plan. 2022. Available: https:\/\/www.wwarn.org\/tools-resources\/wwarn-primaquine-indian-region-study-group-statistical-analysis-plan [Accessed 31 Mar 2023]."},{"key":"2025073012453431000_8.12.e012675.26","unstructured":"National Institute of Health Research . International prospective register of systematic reviews. PROSPERO: CRD42022313730. n.d. Available: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=313730"},{"key":"2025073012453431000_8.12.e012675.27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/CDLI.8.5.891-894.2001","article-title":"Plasmodium Vivax polymorphism in a clinical drug trial","volume":"8","author":"Adak","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"2025073012453431000_8.12.e012675.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1084-1","article-title":"Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium Vivax malaria: a phase III, multicentric, open-label study","volume":"15","author":"Valecha","year":"2016","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.29","first-page":"18","article-title":"Atypical manifestations of Plasmodium Vivax malaria","volume":"39","author":"Mohapatra","year":"2002","journal-title":"Indian J Malariol"},{"key":"2025073012453431000_8.12.e012675.30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4269\/ajtmh.2005.73.1108","article-title":"A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium Vivax malaria in India","volume":"73","author":"Dunne","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2025073012453431000_8.12.e012675.31","doi-asserted-by":"publisher","DOI":"10.1080\/00034980120103225"},{"key":"2025073012453431000_8.12.e012675.32","doi-asserted-by":"publisher","DOI":"10.2307\/3285559"},{"key":"2025073012453431000_8.12.e012675.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(03)90082-4"},{"key":"2025073012453431000_8.12.e012675.34","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02050-12"},{"key":"2025073012453431000_8.12.e012675.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157666","article-title":"Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium Vivax malaria from primary care centres in southwestern India","volume":"11","author":"Saravu","year":"2016","journal-title":"PLoS One"},{"key":"2025073012453431000_8.12.e012675.36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3347\/kjp.2016.54.6.733","article-title":"Therapeutic assessment of primaquine for radical cure of Plasmodium Vivax malaria at primary and tertiary care centres in southwestern India","volume":"54","author":"Kumar","year":"2016","journal-title":"Korean J Parasitol"},{"key":"2025073012453431000_8.12.e012675.37","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-015-0824-y","article-title":"Therapeutic assessment of chloroquine-Primaquine combined regimen in adult cohort of Plasmodium Vivax malaria from a tertiary care hospital in southwestern India","volume":"14","author":"Rishikesh","year":"2015","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154015","article-title":"G6Pd deficiency and antimalarial efficacy for uncomplicated malaria in Bangladesh: a prospective observational study","volume":"11","author":"Ley","year":"2016","journal-title":"PLoS One"},{"key":"2025073012453431000_8.12.e012675.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62568-4"},{"key":"2025073012453431000_8.12.e012675.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2472-5","article-title":"A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of Vivax malaria in South India","volume":"17","author":"Saravu","year":"2018","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/infdis\/jiz126","article-title":"Efficacy of primaquine in preventing short- and long-latency Plasmodium Vivax relapses in Nepal","volume":"220","author":"Rijal","year":"2019","journal-title":"J Infect Dis"},{"key":"2025073012453431000_8.12.e012675.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002861","article-title":"A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium Vivax in Northwest frontier province, Pakistan","volume":"3","author":"Leslie","year":"2008","journal-title":"PLoS One"},{"key":"2025073012453431000_8.12.e012675.43","first-page":"62","article-title":"Comparison of treatment schedules for Plasmodium Vivax infections in the Solomon Islands","volume":"20","author":"Saint-Yves","year":"1977","journal-title":"P N G Med J"},{"key":"2025073012453431000_8.12.e012675.44","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4269\/ajtmh.2008.78.736","article-title":"High-dose primaquine regimens against relapse of Plasmodium Vivax malaria","volume":"78","author":"Krudsood","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"2025073012453431000_8.12.e012675.45","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0428"},{"key":"2025073012453431000_8.12.e012675.46","article-title":"Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium Vivax","volume":"8","author":"Milligan","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025073012453431000_8.12.e012675.47","unstructured":"National Center for Vector Borne Diseases Control (NCVBDC) . Ministry of health and family welfare, government of India. National vector borne disease control programme: malaria. Available: https:\/\/nvbdcp.gov.in\/WriteReadData\/l892s\/nsp_2017-2022.pdf [Accessed 16 Dec 2022]."},{"key":"2025073012453431000_8.12.e012675.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1386-6","article-title":"The haematological consequences of Plasmodium Vivax malaria after chloroquine treatment with and without primaquine: a worldwide antimalarial resistance network systematic review and individual patient data meta-analysis","volume":"17","author":"Commons","year":"2019","journal-title":"BMC Med"},{"key":"2025073012453431000_8.12.e012675.49","doi-asserted-by":"crossref","unstructured":"Rajasekhar M , Simpson JA , Ley B , et al . Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium Vivax malaria: a systematic review and individual patient data meta-analysis [published online ahead of print, 2023 Sep 22]. Lancet Infect Dis 2023. doi:10.1016\/S1473-3099(23)00431-0","DOI":"10.1016\/S1473-3099(23)00431-0"},{"key":"2025073012453431000_8.12.e012675.50","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-144","article-title":"Geographical variation in Plasmodium Vivax relapse","volume":"13","author":"Battle","year":"2014","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.51","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium Vivax malaria","volume":"10","author":"White","year":"2011","journal-title":"Malar J"},{"key":"2025073012453431000_8.12.e012675.52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4269\/ajtmh.1998.59.175","article-title":"Studies on the Plasmodium Vivax relapse pattern in Delhi, India","volume":"59","author":"Adak","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"2025073012453431000_8.12.e012675.53","first-page":"499","article-title":"Relapse\/reinfection patterns of Plasmodium Vivax infection: a four year study","volume":"22","author":"Prasad","year":"1991","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"2025073012453431000_8.12.e012675.54","first-page":"173","article-title":"Studies on Plasmodium Vivax relapse pattern in Kheda district","volume":"33","author":"Srivastava","year":"1996","journal-title":"Indian J Malariol"},{"key":"2025073012453431000_8.12.e012675.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92898-7"},{"key":"2025073012453431000_8.12.e012675.56","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05566-11"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2023-012675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:45:50Z","timestamp":1753904750000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2023-012675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,20]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjgh-2023-012675"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2023-012675","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}